Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Capital Leases (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Capital Leases for 3 consecutive years, with $14.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Leases rose 122.73% year-over-year to $14.5 million, compared with a TTM value of $14.5 million through Dec 2025, up 122.73%, and an annual FY2025 reading of $14.5 million, up 122.73% over the prior year.
  • Capital Leases was $14.5 million for Q4 2025 at BrightSpring Health Services, up from $10.4 million in the prior quarter.
  • Across five years, Capital Leases topped out at $25.0 million in Q3 2024 and bottomed at $6.5 million in Q1 2025.
  • Average Capital Leases over 3 years is $15.8 million, with a median of $14.5 million recorded in 2025.
  • Peak annual rise in Capital Leases hit 122.73% in 2025, while the deepest fall reached 73.48% in 2025.
  • Year by year, Capital Leases stood at $22.5 million in 2023, then crashed by 71.01% to $6.5 million in 2024, then skyrocketed by 122.73% to $14.5 million in 2025.
  • Business Quant data shows Capital Leases for BTSG at $14.5 million in Q4 2025, $10.4 million in Q3 2025, and $8.2 million in Q2 2025.